Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Company to distribute and promote the once-weekly injectable therapy following ...
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, ...
Formycon will complete the development of FYB206, prepare and file the regulator...
The once-daily oral therapy is administered as a 14-day course. Clinical trials ...
Approval enables access to targeted therapy for adults and adolescents aged 12 ...
Manjiri Gharat,FIP India Envoy; VP,SEARPharm Forum of FIP; I/C Principal,K.M.Ku...
Biocon Group Chairperson recognised in Mumbai ceremony for contributions to gl...
Formycon to develop and supply Pembrolizumab biosimilar FYB206, while Zydus Lif...
Researchers say comparing unknown compounds in a patient’s blood or urine to tho...
Het bericht Violence against women and children emerges as major global health c...
A brain–computer interface (BCI), called the Biological Interface System to Cort...
DATA FROM A NEW survey show that U.S. health care organizations are increasing t...
NeurIPS hosted over 24,000 machine learning researchers in San Diego, among whic...
In preclinical studies, D16-M1P2 showed consistent potency in CCNE1-amplified br...
In a Phase III clinical trial, over half of patients who received a limited cour...
HN Summary • UHN surgeons are curing a rare and potentially fatal lung condition...
